Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,801,628
-
Share change
-
+3,176,426
-
Total reported value
-
$20,265,000
-
Price per share
-
$5.33
-
Number of holders
-
22
-
Value change
-
+$17,029,576
-
Number of buys
-
19
-
Number of sells
-
3
Institutional Holders of BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) as of Q2 2021
As of 30 Jun 2021,
BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,801,628 shares.
The largest 10 holders included
Altium Capital Management LP, ARMISTICE CAPITAL, LLC, Kepos Capital LP, MMCAP International Inc. SPC, Hudson Bay Capital Management LP, CVI Holdings, LLC, Murchinson Ltd., SABBY MANAGEMENT, LLC, Redmond Asset Management, LLC, and MARSHALL WACE, LLP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.